597. Dengue viremia in Kenyan children with acute febrile illness
Session: Poster Abstract Session: Oh One World: Infections from Near and Far
Thursday, October 27, 2016
Room: Poster Hall
Background: Dengue virus (DENV) remains the most prevalent arboviral infection worldwide, causing an estimated 400 million infections per year. By mathematical modeling, 16% of DENV infections occur in Africa. However due to lack of routine surveillance programs, the burden of DENV infection in many African countries is largely unknown.

Methods: As a part of an ongoing study on arboviral infection in Kenyan children, we collected blood samples from subjects 1 to 17 years of age who presented with fever of unclear etiology to one of four centers located either in western (Kisumu and Chulaimbo) or coastal Kenya (Ukunda and Msambweni). We tested the samples for the presence of DENV RNA by RT-PCR. DENV RNA positive samples were then serotyped by PCR.

Results: We identified DENV viremia more frequently in subjects with acute febrile illness in western vs. coastal Kenya (9.2% positive [75 of 814 subjects] vs. 0.9% [4 of 435 subjects], respectively, p<0.001). In western Kenya, all four serotypes were identified; 51 samples had serotype 1 (DENV-1), two had DENV-2, thirteen had DENV-3, and two had DENV-4. There were also subjects who had dual infection with two DENV serotypes: one subject with DENV-1+3, three with DENV-1+4, and one with DENV-2+3. Only DENV-1 was identified in samples from coastal Kenya. To investigate the phylogeny of the DENV strains, we performed exploratory next-generation sequence (NGS) on a limited subset of the samples. DENV-1 sequences were over-represented from blood samples of seven subjects from western Kenya (five from Chulaimbo, two from Kisumu) and mapped to a strain from Thailand (accession AF180818) with 98.5-99.4% homology.

Conclusion: Further sequencing experiments will be important for developing a better understanding of the phylogeny of DENV strains currently circulating in Kenya. Together, our preliminary results suggest that DENV may be an important cause of acute febrile illness in Kenyan children, but the incidence and disease burden may differ by geographic location.

David Vu, MD1, Noah Mutai, BS2, Claire Heath, PhD3, Bryson Ndenga, PhD4 and A. Desiree Labeaud, MD, MS1, (1)Stanford University, Stanford, CA, (2)Kenya Medical Research Institute, KISUMU, Kenya, (3)Stanford University, Palo Alto, CA, (4)Kenya Medical Research Institute, Kisumu, Kenya

Disclosures:

D. Vu, None

N. Mutai, None

C. Heath, None

B. Ndenga, None

A. D. Labeaud, None

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.